How Health1st compares to Redox, Rhapsody & Mirth
Three ways to move HL7 and FHIR between systems — a managed API network, an enterprise engine, and free open source. Here's an honest look at where an AI-native, bidirectional translation platform fits, and where it doesn't.
- AI-native mapping vs. hand-built interfaces
- On-prem / VPC control vs. someone else's network
- Transparent usage-credit pricing vs. quote-only
MSH|^~\&|EPIC|HOSP|H1ST|DST|202601..||ADT^A01|
PID|1||MRN12345^^^HOSP^MR||DOE^JOHN^A||
19701225|M|||123 MAIN ST^^AUSTIN^TX
PV1|1|I|ICU^101^A|||...admit...
DG1|1|I10|E11.9^Type 2 diabetes mellitusAgent
{ "resourceType": "Patient",
"identifier": [{ "value": "MRN12345" }],
"name": [{ "family": "Doe",
"given": ["John","A"] }],
"gender": "male",
"birthDate": "1970-12-25" }
{ "resourceType": "Condition",
"code": { "coding": [{
"system": "…/icd-10-cm",
"code": "E11.9" }] } }In short
Health1st is an AI-native, bidirectional HL7 v2 ↔ FHIR translation platform. Compared with the incumbents: Redox is a managed API network (fast to connect, but you live inside their cloud and pay per transaction on top of a ~$35k/month floor); Rhapsody is the enterprise engine standard (deep and reliable, but config-heavy and enterprise-priced); Mirth Connect is free open source (powerful, but you own all the ops, scaling and support). Health1st's edge is AI-generated mapping with a human in the loop, deployment you control (on-prem or private VPC), and transparent usage-credit pricing that undercuts the managed floor.
Capability comparison
Capabilities that matter when you're choosing how to translate and route healthcare data. Competitor pricing and timing figures are public estimates and directional benchmarks, not quotes.
| Capability | Health1st | Redox | Rhapsody | Mirth Connect |
|---|---|---|---|---|
| Bidirectional HL7 v2 ↔ FHIR | ||||
| AI-native mapping (agent-generated) | ||||
| No-code mapping studio | ||||
| On-prem / private VPC deployment | ||||
| Custom / edge message types | ||||
| Transparent, published pricing | ||||
| Typical days to first interface | Days | Weeks | Weeks–months | Months (DIY) |
| CMS-0057-F FHIR APIs ready | ||||
| Vendor support & validation included |
✓ = supported · ~ = partial / add-on / model-dependent · ✕ = not supported natively. Rhapsody markets “Rhapsody Axon” agentic AI; Redox offers modern APIs rather than AI-led mapping; Mirth has no native AI mapping.
What AI-native actually changes
“We use AI” is no longer a differentiator — even Rhapsody now markets agentic AI. The difference is where AI sits in the workflow and what it measurably changes.
Mapping is generated, not typed
The Mapping Agent proposes a full v2↔FHIR mapping from your real messages — PID→Patient, PV1→Encounter, DG1 (ICD-10 E11.9)→Condition — which an engineer reviews and approves. Interfaces that took weeks land in days.
You own the deployment
Run Health1st in your own private VPC or fully on-prem. PHI never has to leave your boundary, and you're not limited to a vendor's pre-connected endpoint list — a hard limit of pure API-network models.
Pricing you can read
Platform subscription plus usage credits, published in tiers. No opaque enterprise quote, and translation credits priced well under Redox's $0.50–$2.00 per transaction.
Bidirectional, not just ingestion
Round-trip translation both ways — v2→FHIR and FHIR→v2 — so legacy systems and modern FHIR APIs stay in sync without a second one-way pipeline bolted on.
Custom & edge message types
Non-standard Z-segments, local code systems and vendor quirks are first-class inputs to the mapping agent — not out-of-scope like a fixed network connector.
Built for CMS-0057-F
Patient Access, Provider Access, Payer-to-Payer and Prior Auth (PARDD) FHIR APIs on the mandated stack — FHIR R4.0.1, US Core STU 3.1.1, SMART, Bulk Data, OIDC — ahead of the Jan 1 2027 deadline.
Dig into a head-to-head
Fair, factual breakdowns — including when the other vendor is genuinely the better choice.
Health1st vs Redox
Integration-as-a-service with 12,000+ connected orgs vs. an AI-native platform you deploy and control. Where a managed network wins, where on-prem control and usage-fair pricing win.
Read the Redox comparisonHealth1st vs Rhapsody & Mirth
The #1 KLAS enterprise engine and the free open-source standard vs. AI-native mapping with support and validation built in. Faster time-to-interface without the DIY tax or the enterprise price.
Read the Rhapsody & Mirth comparisonSecurity & Compliance
Enterprise-grade trust, stated honestly
Protecting PHI is non-negotiable. Here's exactly where our certifications stand — no overclaiming.
Compliant · BAAs available
Audit in progress
On roadmap
Native, by design
AWS HIPAA-eligible infrastructure · Business Associate Agreements (BAAs) · Encryption in transit & at rest · See our security details →
Frequently asked questions
See how the comparison plays out on your data
Bring your own HL7 message types and CMS-0057-F requirements. We'll show a live v2 ↔ FHIR translation — no obligation.